51˶

Neurology

Multiple Sclerosis

More in Multiple Sclerosis

Galantamine and Alzheimer's; Fork Sign Landmark; Instagram in Neurology Education

News and commentary from the world of neurology and neuroscience

Nov 12, 2024
Neuro Break over a computer rendering of neurons.
Year in Review: Multiple Sclerosis

A look back at newsworthy stories of 2024

Nov 08, 2024
2024 YEAR IN REVIEW multiple sclerosis over a computer rendering of the demyelination of a neuron.
Weekend Warriors and Dementia; Iron Chelation and Alzheimer's; Neuro Drug Costs Rise

News and commentary from the world of neurology and neuroscience

Nov 05, 2024
Neuro Break over a computer rendering of neurons.
Alzheimer's Trials Investigated; Chronic Pain Predicted; Dementia Drugs and AMD

News and commentary from the world of neurology and neuroscience

Oct 29, 2024
Neuro Break over a computer rendering of neurons.
MIND Diet and Cognitive Decline; Gene Therapy for Parkinson's; Curbing MS Fatigue

News and commentary from the world of neurology and neuroscience

Oct 22, 2024
Neuro Break over a computer rendering of neurons.
Alzheimer's-Heparin Link; Two Phases of Alzheimer's Damage; Prion Disease Testing

News and commentary from the world of neurology and neuroscience

Oct 15, 2024
Neuro Break over a computer rendering of neurons.
Some Cancers Occur More Frequently in Multiple Sclerosis Patients

Bladder, brain, and cervical cancer risks were higher in people with MS

Oct 09, 2024
A computer rendering of nerve cells.
How the Brain Clears Waste; Masked Benzodiazepine Taper; New Hope for PML

News and commentary from the world of neurology and neuroscience

Oct 08, 2024
Neuro Break over a computer rendering of neurons.
Hearing Loss-Cognition Link; Circadian Brain Changes; Repetitive Head Impact Markers

News and commentary from the world of neurology and neuroscience

Oct 01, 2024
Neuro Break over a computer rendering of neurons.
McDonald Criteria Revisions Signal Shift Toward MS as a Biologically Based Disease

Some cases of radiologically isolated syndrome will be considered multiple sclerosis

Sep 23, 2024
ECTRIMS over a photo of Bella Center Copenhagen in Copenhagen, Denmark.
Women With MS Less Likely to Receive Treatment Than Men

Is "therapeutic inertia" to blame?

Sep 21, 2024
ECTRIMS over a photo of Bella Center Copenhagen in Copenhagen, Denmark.
Kids With MS May Have Better Outcomes When Started on High-Efficacy Treatment Early

Starting monoclonal antibody therapy during childhood reduced long-term disability

Sep 20, 2024
ECTRIMS over a photo of Bella Center Copenhagen in Copenhagen, Denmark.
Tolebrutinib Slows Disability in Non-Relapsing Secondary Progressive MS

Liver toxicity may still be a concern

Sep 20, 2024
ECTRIMS over a photo of Bella Center Copenhagen in Copenhagen, Denmark.
Blood Markers Help Predict MS Disease Progression

Patients with high NfL at disease onset may benefit from high-efficacy treatments

Sep 19, 2024
ECTRIMS over a photo of Bella Center Copenhagen in Copenhagen, Denmark.
More in Multiple Sclerosis

1.00 CME Credits
Exploring Novel Treatment Targets and Emerging Therapies for Multiple Sclerosis

0.25 CME Credits
Enhancing Identification and Assessment of Bulbar-Onset Amyotrophic Lateral Sclerosis (ALS) and ALS-Related Cognitive Impairment

0.75 CME Credits
The Latest Evidence and Barriers to the Integration of Emerging Targeted Therapies in Adult Diffuse Low-Grade Glioma Care

0.50 CME Credits
Integrating Targeted Therapies Into Clinical Practice for Pediatric Low-Grade Glioma

0.75 CME Credits
Enhancing the Assessment and Treatment of Mid-Stage Parkinson's Disease

1.00 CME Credits
Aligning Clinical Practices With the Latest Evidence in Advanced Parkinson's Disease Management

0.25 CME Credits
The Role of Neurology Care Teams in Caring for Patients With Multiple Myeloma Receiving Bispecific Antibodies

0.25 CME Credits
Clinical Mic Drop: The Latest Innovations on MEK Therapies for Neurofibromatosis Type 1-Associated Plexiform Neurofibromas